Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Dec 15, 2025

SELL
$1.42 - $3.18 $7,100 - $15,900
-5,000 Reduced 25.0%
15,000 $44,000
Q2 2025

Jul 30, 2025

BUY
$0.9 - $1.63 $9,000 - $16,299
10,000 Added 100.0%
20,000 $28,000
Q1 2025

Apr 17, 2025

BUY
$1.23 - $2.06 $12,300 - $20,600
10,000 New
10,000 $12,000

Others Institutions Holding ALEC

About Alector, Inc.


  • Ticker ALEC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 82,563,904
  • Market Cap $102M
  • Description
  • Alector, Inc., a clinical stage biopharmaceutical company, develops therapies for the treatment of neurodegeneration diseases. Its products include AL001, a humanized recombinant monoclonal antibody, which is in Phase III clinical trial for the treatment of frontotemporal dementia, Alzheimer's, Parkinson's, and amyotrophic lateral sclerosis dise...
More about ALEC
Track This Portfolio

Track Fny Investment Advisers, LLC Portfolio

Follow Fny Investment Advisers, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fny Investment Advisers, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fny Investment Advisers, LLC with notifications on news.